School of Engineering
Showing 1-20 of 45 Results
-
Grace H Hawthorne
Adjunct Professor, d.school
BioGrace Hawthorne is an entrepreneur, artist, author and educator. She is the Founder/CEO of Paper Punk, an award winning Origami meets LEGO mashup that helps people exercise their creativity and Foldmade, an innovative work supply system that helps people get stuff done. As an Adjunct Professor at Stanford University’s design institute (aka: the d.school), she teaches courses on creativity and failure and started a groundbreaking research project on creative capacity building published in Science and covered by Wired magazine. Previously, she founded ReadyMade, the culturally groundbreaking design magazine that ignited the maker movement, and led its acquisition by Meredith Corporation (NASDAQ: MDP). She co-authored the critically acclaimed book on reuse design, ReadyMade: How to Make (Almost) Everything (Random House/Potter). Her artwork has been exhibited in several national museums including the Smithsonian Cooper-Hewitt Design Museum Triennial. Her products can be found on shelves of mass retailers nationwide. Grace has dedicated her life to making things and experiences that cultivate human creativity through the marriage of art + commerce.
-
John Higgins
Adjunct Professor, Materials Science and Engineering
BioJohn received a BS in biochemistry from Albright College and his Ph.D. in synthetic organic chemistry from Brown University. After completing a Postdoctoral Fellowship at the Sloan-Kettering Cancer Institute in NYC in the departments of Positron Emission Tomography and Neurology, he joined the Medicinal Chemistry Discovery group at Johnson Matthey Biomedical. There he made several significant contributions to early research projects on new Pt- antitumor drugs and peptide-based diagnostic radio-imaging agents. After nearly a decade as a discovery med chemist, he moved on to drug development in positions of increasing responsibility at J&J and Sanofi-Aventis. He and his teams have specialized in the areas of drug delivery, solid state chemistry and biomaterials in relation to improving the bioperformance of therapeutic agents. Towards this end, he has led the successful implementation of a wide range of methodologies into drug discovery space including prodrug design for enhanced solubility/permeability, miniaturized polymeric amorphous dispersions and nanoparticle technologies.
John currently is Executive Director of the Discovery Pharmaceutical Sciences department at Merck’s Discovery Center. In this multidisciplinary role, he is responsible for oversight of the biopharmaceutical and drug delivery aspects of Merck’s discovery programs (small molecules and peptides) as well as the identification of new enabling technologies. Over his over 30 year pharma career, he is co-inventor on 13 US Patents and author of numerous and diverse publications and book chapters in the fields of organic, solid state & medicinal chemistry and drug delivery.
John also currently serves as an Adjunct Associate Professor at the University of Pennsylvania School of Medicine, where he regularly teaches classes in various aspects of drug discovery and development.